Here, we further advance the notion that IRF8 exhibits antitumor activities, perhaps, distinct from its tumor suppressor functions, and show for the first time that IRF8 acts as a negative regulator of MMP3 expression, a member of the MMP family previously implicated in mammary tumorigenesis and other solid cancers [27]. Here, IRF8 is linked to neoplasm.